Abt Associates receives CDC contract to study flu vaccine

Abt Associates announced on Monday that it was awarded a $51.6 million contract by the Centers for Disease Control and Prevention to study the effectiveness of the flu vaccine.

Abt said it would conduct the studies in multiple settings, including inpatient, outpatient, pregnant women and infants. Abt currently holds three contracts with the CDC to study flu vaccine effectiveness and will use existing procedures and infrastructure to start new studies.

"Influenza is a serious threat to public health, affecting tens of thousands of Americans each year," Deborah Klein Walker, the vice president of Abt, said. "We are pleased to continue our work supporting the CDC's vaccination initiatives and advancing research on conducting influenza studies during a pandemic."

Abt will use its subsidiary Abt SRBI for surveys and research during the study.

Clark Abt created Abt Associates in 1965. The company used interdisciplinary social science research to answer social, economic and technological questions, beginning with the nation's war on poverty. Abt Associates' studies have contributed to national programs such as Section 8 housing and Head Start, according to the company's website.

The research company currently has offices around the United States and in more than 40 countries, and is consistently listed as one of the top 20 global research firms.